ARMATA PHARMACEUTICALS, INC. Operating Income
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Operating Income of -$10.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$10.31M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$8.79M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$13.82M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$7.78M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2025 was -$36.63M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2024 was -$42.44M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$40.89M.
- ARMATA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$36.95M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.31M 10-Q · filed 2026-08-12 | -$19.10M 10-Q · filed 2026-08-12 | -$32.92M derived: sum of 3 quarters · filed 2026-08-12 | -$40.70M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$8.79M 10-Q · filed 2026-05-13 | -$22.61M derived: sum of 2 quarters · filed 2026-05-13 | -$30.38M derived: sum of 3 quarters · filed 2026-05-13 | -$37.23M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$21.60M derived: sum of 2 quarters · filed 2026-03-25 | -$28.44M derived: sum of 3 quarters · filed 2026-08-12 | -$36.63M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$7.78M 10-Q · filed 2025-11-12 | -$14.62M derived: sum of 2 quarters · filed 2026-08-12 | -$22.81M 10-Q · filed 2025-11-12 | -$33.35M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$6.84M 10-Q · filed 2026-08-12 | -$15.04M 10-Q · filed 2026-08-12 | -$25.57M derived: sum of 3 quarters · filed 2026-08-12 | -$35.33M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$8.19M 10-Q · filed 2026-05-13 | -$18.73M derived: sum of 2 quarters · filed 2026-05-13 | -$28.49M derived: sum of 3 quarters · filed 2026-05-13 | -$40.40M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$20.30M derived: sum of 2 quarters · filed 2026-03-25 | -$32.21M derived: sum of 3 quarters · filed 2026-03-25 | -$42.44M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$9.76M 10-Q · filed 2025-11-12 | -$21.67M derived: sum of 2 quarters · filed 2025-11-12 | -$31.90M 10-Q · filed 2025-11-12 | -$41.48M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$11.91M 10-Q · filed 2025-08-12 | -$22.14M 10-Q · filed 2025-08-12 | -$31.72M derived: sum of 3 quarters · filed 2025-08-12 | -$42.06M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$10.23M 10-Q · filed 2025-05-14 | -$19.81M derived: sum of 2 quarters · filed 2025-05-14 | -$30.14M derived: sum of 3 quarters · filed 2025-05-14 | -$39.77M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$19.91M derived: sum of 2 quarters · filed 2025-03-21 | -$29.54M derived: sum of 3 quarters · filed 2025-03-21 | -$40.89M 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | -$10.34M 10-Q · filed 2024-11-13 | -$19.96M derived: sum of 2 quarters · filed 2024-11-13 | -$31.31M 10-Q · filed 2024-11-13 | -$41.64M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$9.63M 10-Q · filed 2024-08-13 | -$20.98M 10-Q · filed 2024-08-13 | -$31.30M derived: sum of 3 quarters · filed 2024-08-13 | -$39.93M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$11.35M 10-Q · filed 2024-05-07 | -$21.67M derived: sum of 2 quarters · filed 2024-05-07 | -$30.30M derived: sum of 3 quarters · filed 2024-05-07 | -$39.52M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$18.95M derived: sum of 2 quarters · filed 2024-03-21 | -$28.17M derived: sum of 3 quarters · filed 2024-03-21 | -$36.95M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | -$8.62M 10-Q · filed 2023-11-14 | -$17.84M derived: sum of 2 quarters · filed 2023-11-14 | -$26.62M 10-Q · filed 2023-11-14 | -$32.67M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$9.22M 10-Q · filed 2023-08-14 | -$18.00M 10-Q · filed 2023-08-14 | -$24.04M derived: sum of 3 quarters · filed 2023-08-14 | -$30.19M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$8.78M 10-Q · filed 2023-05-11 | -$14.82M derived: sum of 2 quarters · filed 2023-05-11 | -$20.97M derived: sum of 3 quarters · filed 2023-05-11 | -$27.16M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$12.19M derived: sum of 2 quarters · filed 2023-03-16 | -$18.39M derived: sum of 3 quarters · filed 2023-03-16 | -$23.82M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | -$6.14M 10-Q · filed 2022-11-09 | -$12.34M derived: sum of 2 quarters · filed 2022-11-09 | -$17.77M 10-Q · filed 2022-11-09 | -$24.23M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$6.20M 10-Q · filed 2022-08-11 | -$11.63M 10-Q · filed 2022-08-11 | -$18.08M derived: sum of 3 quarters · filed 2022-08-11 | -$23.71M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$5.43M 10-Q · filed 2022-05-12 | -$11.89M derived: sum of 2 quarters · filed 2022-05-12 | -$17.51M derived: sum of 3 quarters · filed 2022-05-12 | -$22.10M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$12.08M derived: sum of 2 quarters · filed 2022-03-17 | -$16.67M derived: sum of 3 quarters · filed 2022-03-17 | -$21.59M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$5.62M 10-Q · filed 2021-11-10 | -$10.21M derived: sum of 2 quarters · filed 2021-11-10 | -$15.13M 10-Q · filed 2021-11-10 | -$19.51M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$4.59M 10-Q · filed 2021-08-12 | -$9.51M 10-Q · filed 2021-08-12 | -$13.89M derived: sum of 3 quarters · filed 2021-08-12 | -$20.66M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$4.92M 10-Q · filed 2021-05-13 | -$9.30M derived: sum of 2 quarters · filed 2021-05-13 | -$16.07M derived: sum of 3 quarters · filed 2021-05-13 | -$21.23M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$11.15M derived: sum of 2 quarters · filed 2021-03-18 | -$16.31M derived: sum of 3 quarters · filed 2021-03-18 | -$19.75M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$6.78M 10-Q · filed 2020-11-12 | -$11.94M derived: sum of 2 quarters · filed 2020-11-12 | -$15.38M 10-Q · filed 2020-11-12 | -$18.17M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$5.16M 10-Q · filed 2020-08-13 | -$8.60M 10-Q · filed 2020-08-13 | -$11.39M derived: sum of 3 quarters · filed 2020-08-13 | -$13.82M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$3.44M 10-Q · filed 2020-05-14 | -$3.61M 10-Q · filed 2019-05-06 | -$6.24M derived: sum of 2 quarters · filed 2020-05-14 | -$8.66M derived: sum of 3 quarters · filed 2020-05-14 | -$11.51M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$5.22M derived: sum of 2 quarters · filed 2020-03-19 | -$8.07M derived: sum of 3 quarters · filed 2020-03-19 | -$17.66M 10-K · filed 2020-03-19 | -$12.52M 10-K · filed 2019-03-25 | |||
| 2018-09-30 | -$2.43M 10-Q · filed 2019-11-12 | -$1.64M 10-Q · filed 2018-11-08 | -$5.27M derived: sum of 2 quarters · filed 2019-11-12 | -$14.86M 10-Q · filed 2019-11-12 | -$7.74M 10-Q · filed 2018-11-08 | -$10.69M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$2.84M 10-Q · filed 2019-08-14 | -$3.05M 10-Q · filed 2018-08-09 | -$12.44M 10-Q · filed 2019-08-14 | -$6.11M 10-Q · filed 2018-08-09 | -$8.26M derived: sum of 3 quarters · filed 2019-08-14 | -$9.01M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$3.06M 10-Q · filed 2019-05-06 | -$5.42M derived: sum of 2 quarters · filed 2019-05-06 | -$6.17M derived: sum of 3 quarters · filed 2019-05-06 | -$15.85M derived: sum of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | -$2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$3.11M derived: sum of 2 quarters · filed 2019-03-25 | -$12.80M derived: sum of 3 quarters · filed 2019-03-25 | -$16.16M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | -$746.00K 10-Q · filed 2018-11-08 | -$10.43M derived: sum of 2 quarters · filed 2018-11-08 | -$13.79M 10-Q · filed 2018-11-08 | -$25.66M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$9.69M 10-Q · filed 2018-08-09 | -$13.04M 10-Q · filed 2018-08-09 | -$24.91M derived: sum of 3 quarters · filed 2018-08-09 | -$28.32M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$3.36M 10-Q · filed 2018-05-15 | -$15.22M derived: sum of 2 quarters · filed 2018-05-15 | -$18.63M derived: sum of 3 quarters · filed 2018-05-15 | -$22.22M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -$11.86M 10-K · filed 2017-03-27 | -$15.27M derived: sum of 2 quarters · filed 2017-11-14 | -$18.86M derived: sum of 3 quarters · filed 2017-11-14 | -$23.38M 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | -$3.41M 10-Q · filed 2017-11-14 | -$7.00M derived: sum of 2 quarters · filed 2017-11-14 | -$11.51M 10-Q · filed 2017-11-14 | -$14.45M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | -$3.59M 10-Q · filed 2017-08-14 | -$8.11M 10-Q · filed 2017-08-14 | -$11.05M derived: sum of 3 quarters · filed 2017-08-14 | -$13.47M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$4.52M 10-Q · filed 2017-05-15 | -$7.46M derived: sum of 2 quarters · filed 2017-05-15 | -$9.89M derived: sum of 3 quarters · filed 2017-05-15 | -$12.48M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$2.94M 10-K · filed 2017-03-27 | -$5.37M derived: sum of 2 quarters · filed 2017-03-27 | -$7.96M derived: sum of 3 quarters · filed 2017-03-27 | -$10.23M 10-K · filed 2017-03-27 | ||||
| 2015-09-30 | -$2.43M 10-K · filed 2017-03-27 | -$5.02M derived: sum of 2 quarters · filed 2017-03-27 | -$7.29M 10-Q · filed 2016-11-10 | -$9.88M derived: sum of 4 quarters · filed 2017-03-27 | ||||
| 2015-06-30 | -$2.59M 10-K · filed 2017-03-27 | -$4.86M 10-Q · filed 2016-08-15 | -$7.46M derived: sum of 3 quarters · filed 2017-03-27 | -$12.69M derived: sum of 4 quarters · filed 2017-03-27 | ||||
| 2015-03-31 | -$2.27M 10-K · filed 2017-03-27 | -$4.86M derived: sum of 2 quarters · filed 2017-03-27 | -$10.10M derived: sum of 3 quarters · filed 2017-03-27 | -$13.84M derived: sum of 4 quarters · filed 2017-03-27 | ||||
| 2014-12-31 | -$2.60M 10-K · filed 2016-03-30 | -$7.83M derived: sum of 2 quarters · filed 2016-03-30 | -$11.58M derived: sum of 3 quarters · filed 2016-03-30 | -$14.11M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | -$5.23M 10-K · filed 2016-03-30 | -$4.95M 10-Q · filed 2014-11-14 | -$8.98M derived: sum of 2 quarters · filed 2016-03-30 | -$11.51M 10-Q · filed 2015-11-16 | -$11.26M 10-Q · filed 2014-11-14 | -$14.10M derived: sum of 4 quarters · filed 2016-03-30 | ||
| 2014-06-30 | -$3.75M 10-K · filed 2016-03-30 | -$3.72M 10-Q · filed 2014-09-12 | -$6.28M 10-Q · filed 2015-08-13 | -$6.32M 10-Q · filed 2014-09-12 | -$8.87M derived: sum of 3 quarters · filed 2016-03-30 | -$11.21M derived: sum of 4 quarters · filed 2016-03-30 | ||
| 2014-03-31 | -$2.53M 10-K · filed 2016-03-30 | -$2.59M 10-Q · filed 2014-05-20 | -$5.12M derived: sum of 2 quarters · filed 2016-03-30 | -$7.46M derived: sum of 3 quarters · filed 2016-03-30 | -$13.59M derived: sum of 4 quarters · filed 2016-03-30 | |||
| 2013-12-31 | -$2.59M derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | -$4.93M derived: sum of 2 quarters · filed 2015-04-15 | -$11.05M derived: sum of 3 quarters · filed 2015-04-15 | -$12.38M 10-Q/A · filed 2015-04-15 | -$12.44M 10-Q · filed 2014-05-20 | |||
| 2013-09-30 | -$2.34M 10-Q/A · filed 2015-04-15 | -$2.32M 10-Q · filed 2014-11-14 | -$8.46M derived: sum of 2 quarters · filed 2015-04-15 | -$9.80M 10-Q/A · filed 2015-04-15 | -$9.82M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$6.12M 10-Q/A · filed 2015-04-15 | -$6.28M 10-Q · filed 2014-09-12 | -$7.46M 10-Q/A · filed 2015-04-15 | -$7.50M 10-Q · filed 2014-09-12 | ||||
| 2013-03-31 | -$1.33M 10-Q/A · filed 2015-04-15 | -$1.21M 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |